Cover Image
市場調查報告書

免疫球蛋白E (IgE) 過敏血液檢驗:醫療設備的開發平台評估

IgE Allergy Blood Tests - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 356280
出版日期 內容資訊 英文 41 Pages
訂單完成後即時交付
價格
Back to Top
免疫球蛋白E (IgE) 過敏血液檢驗:醫療設備的開發平台評估 IgE Allergy Blood Tests - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年03月11日 內容資訊: 英文 41 Pages
簡介

本報告提供全球免疫球蛋白E (IgE) 過敏血液檢驗市場上的主要開發中產品 (醫療設備) 及其臨床實驗的進展調查,再加上產品特性比較分析 (臨床實驗的各進展階段) ,並彙整主要企業簡介及代表性產品,近來的市場動靜 (授權合約·產業聯盟等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 免疫球蛋白E (IgE) 過敏血液檢驗概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:估計各認證時期

第4章 臨床實驗中的開發中產品:各企業

  • IgE過敏血液檢查裝置的企業:各臨床實驗階段的開發中產品
  • IgE過敏血液檢查裝置:各臨床實驗階段的開發中產品

第5章 IgE過敏血液檢查裝置市場:企業·產品概要

  • Abionic SA
    • 開發中產品及進行中的臨床實驗概要
  • Amerimmune
  • Atomo Diagnostics Pty Limited
  • AXO Science S.A.S.
  • Biovator AB
  • Children's Hospital Boston
  • China Medical Technologies, Inc.
  • Cytognos, S.L.
  • HOB Biotech Group Co., Ltd.
  • Hycor Biomedical Inc.
  • Institut fur Produktqualitat GmbH
  • The Binding Site Group Ltd.
  • The University of Queensland
  • University of Connecticut Health Center
  • University of Nottingham
  • VEGA Ltd

第6章 IgE過敏血液檢驗市場:目前的趨勢

第7章 附錄

圖表一覽

目錄
Product Code: GDME0151EPD

GlobalData's Medical Devices sector report, "IgE Allergy Blood Tests - Medical Devices Pipeline Assessment, 2016" provides an overview of IgE Allergy Blood Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key IgE Allergy Blood Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the IgE Allergy Blood Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of IgE Allergy Blood Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of IgE Allergy Blood Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. IgE Allergy Blood Tests Overview

3. Products under Development

  • 3.1. IgE Allergy Blood Tests - Pipeline Products by Stage of Development
  • 3.2. IgE Allergy Blood Tests - Pipeline Products by Territory
  • 3.3. IgE Allergy Blood Tests - Pipeline Products by Regulatory Path
  • 3.4. IgE Allergy Blood Tests - Pipeline Products by Estimated Approval Date

4. IgE Allergy Blood Tests - Pipeline Products under Development by Companies

  • 4.1. IgE Allergy Blood Tests Companies - Pipeline Products by Stage of Development
  • 4.2. IgE Allergy Blood Tests - Pipeline Products by Stage of Development

5. IgE Allergy Blood Tests Companies and Product Overview

  • 5.1. Abionic SA Company Overview
    • 5.1.1. Abionic SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Amerimmune Company Overview
    • 5.2.1. Amerimmune Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Atomo Diagnostics Pty Limited Company Overview
    • 5.3.1. Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. AXO Science S.A.S. Company Overview
    • 5.4.1. AXO Science S.A.S. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Biovator AB Company Overview
    • 5.5.1. Biovator AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Children's Hospital Boston Company Overview
    • 5.6.1. Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. China Medical Technologies, Inc. Company Overview
    • 5.7.1. China Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Cytognos, S.L. Company Overview
    • 5.8.1. Cytognos, S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. HOB Biotech Group Co., Ltd. Company Overview
    • 5.9.1. HOB Biotech Group Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Hycor Biomedical Inc. Company Overview
    • 5.10.1. Hycor Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Institut fur Produktqualitat GmbH Company Overview
    • 5.11.1. Institut fur Produktqualitat GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. The Binding Site Group Ltd. Company Overview
    • 5.12.1. The Binding Site Group Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. The University of Queensland Company Overview
    • 5.13.1. The University of Queensland Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. University of Connecticut Health Center Company Overview
    • 5.14.1. University of Connecticut Health Center Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. University of Nottingham Company Overview
    • 5.15.1. University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. VEGA Ltd Company Overview
    • 5.16.1. VEGA Ltd Pipeline Products & Ongoing Clinical Trials Overview

6. IgE Allergy Blood Tests- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: IgE Allergy Blood Tests - Pipeline Products by Stage of Development
  • Table 2: IgE Allergy Blood Tests - Pipeline Products by Territory
  • Table 3: IgE Allergy Blood Tests - Pipeline Products by Regulatory Path
  • Table 4: IgE Allergy Blood Tests - Pipeline Products by Estimated Approval Date
  • Table 5: IgE Allergy Blood Tests Companies - Pipeline Products by Stage of Development
  • Table 6: IgE Allergy Blood Tests - Pipeline Products by Stage of Development
  • Table 7: Abionic SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 8: abioKIT - Product Status
  • Table 9: abioKIT - Product Description
  • Table 10: Amerimmune Pipeline Products & Ongoing Clinical Trials Overview
  • Table 11: Basophile Panel - Product Status
  • Table 12: Basophile Panel - Product Description
  • Table 13: CD69 and IgE Receptor Expression Assay - Product Status
  • Table 14: CD69 and IgE Receptor Expression Assay - Product Description
  • Table 15: Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: AtomoRapid - Allergy - Product Status
  • Table 17: AtomoRapid - Allergy - Product Description
  • Table 18: AXO Science S.A.S. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: Companion Diagnostic Test - Allergy - Product Status
  • Table 20: Companion Diagnostic Test - Allergy - Product Description
  • Table 21: Diagnostic Test - Allergy - Product Status
  • Table 22: Diagnostic Test - Allergy - Product Description
  • Table 23: Biovator AB Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: Cytokine Profile Assay - Product Status
  • Table 25: Cytokine Profile Assay - Product Description
  • Table 26: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: Biomarker Assay - Allergy - Product Status
  • Table 28: Biomarker Assay - Allergy - Product Description
  • Table 29: China Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 30: Diagnostic Assay - Total IgE - Product Status
  • Table 31: Diagnostic Assay - Total IgE - Product Description
  • Table 32: Cytognos, S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: Diagnosis Flow Cytometry Kit - Type 1 Hypersensitivity - Product Status
  • Table 34: Diagnosis Flow Cytometry Kit - Type 1 Hypersensitivity - Product Description
  • Table 35: HOB Biotech Group Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: HOB Biotech Diagnostic Assay - Allergy - Product Status
  • Table 37: HOB Biotech Diagnostic Assay - Allergy - Product Description
  • Table 38: Hycor Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: HYTEC 288 PLUS - Eosinophil Cationic Protein Test - Product Status
  • Table 40: HYTEC 288 PLUS - Eosinophil Cationic Protein Test - Product Description
  • Table 41: HYTEC 288 PLUS - Tryptase Test - Product Status
  • Table 42: HYTEC 288 PLUS - Tryptase Test - Product Description
  • Table 43: Institut fur Produktqualitat GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: Diagnostic Test - Allergy - Product Status
  • Table 45: Diagnostic Test - Allergy - Product Description
  • Table 46: The Binding Site Group Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 47: SPAplus - Immunoglobulin E Assay - Product Status
  • Table 48: SPAplus - Immunoglobulin E Assay - Product Description
  • Table 49: The University of Queensland Pipeline Products & Ongoing Clinical Trials Overview
  • Table 50: Diagnostic Assay - Allergy - Product Status
  • Table 51: Diagnostic Assay - Allergy - Product Description
  • Table 52: University of Connecticut Health Center Pipeline Products & Ongoing Clinical Trials Overview
  • Table 53: Ultrasensitive Peanut Allergy Test - Product Status
  • Table 54: Ultrasensitive Peanut Allergy Test - Product Description
  • Table 55: University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview
  • Table 56: Allergy Test - Product Status
  • Table 57: Allergy Test - Product Description
  • Table 58: VEGA Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: Microarray Based Allergen Diagnostic Kit - Product Status
  • Table 60: Microarray Based Allergen Diagnostic Kit - Product Description
  • Table 61: Glossary

List of Figures

  • Figure 1: IgE Allergy Blood Tests - Pipeline Products by Stage of Development
  • Figure 2: IgE Allergy Blood Tests - Pipeline Products by Territory
  • Figure 3: IgE Allergy Blood Tests - Pipeline Products by Regulatory Path
  • Figure 4: IgE Allergy Blood Tests - Pipeline Products by Estimated Approval Date
Back to Top